August 20, 2014 8:26 PM ET

Biotechnology

Company Overview of 3-V Biosciences, Inc.

Executive Profile

Merdad V. Parsey M.D., Ph.D.

Chief Executive Officer, President and Director, 3-V Biosciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Dr. Merdad V. Parsey, MD, PhD has been the Chief Executive Officer and President at 3-V Biosciences, Inc. since October 2010. Dr. Parsey held positions of increasing responsibility at Genentech, Inc., a member of the Roche Group, he served as Senior Group Medical Director in Genentech Research and Early Development, overseeing early clinical development in multiple therapeutic areas. Prior to his tenure with Genentech, Dr. Parsey worked at Sepracor, Regeneron and Merck, ...

Corporate Headquarters

1050 Hamilton Court
Menlo Park, California 94025

United States

Phone: 650-561-8600
Fax: --

Board Members Memberships

Chief Executive Officer, President and Director

Education

PhD
University of Maryland
MD
University of Maryland

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact 3-V Biosciences, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.